Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
33703 | 87 | 42.4 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1650 | 6377 | BICLUSTERING//PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EDGE BIOMARKER | Author keyword | 8 | 100% | 6% | 5 |
2 | SIBS NOVO NORDISK TRANSLAT PREDIABET | Address | 6 | 28% | 20% | 17 |
3 | RESP18 | Author keyword | 4 | 75% | 3% | 3 |
4 | ABORAT INNOVAT MATH MODELLING | Address | 4 | 27% | 15% | 13 |
5 | DYNAMICAL NETWORK BIOMARKER | Author keyword | 3 | 100% | 3% | 3 |
6 | NETWORK BIOMARKER | Author keyword | 2 | 44% | 5% | 4 |
7 | TCM COMPLEX SYST | Address | 2 | 44% | 5% | 4 |
8 | SYST BIOLINNOVAT CELL SIGNALING NETW | Address | 2 | 50% | 3% | 3 |
9 | PROTEOME REGULATION NETWORK | Author keyword | 1 | 100% | 2% | 2 |
10 | SHANGHAI LONGHUA HOSP | Address | 1 | 40% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EDGE BIOMARKER | 8 | 100% | 6% | 5 | Search EDGE+BIOMARKER | Search EDGE+BIOMARKER |
2 | RESP18 | 4 | 75% | 3% | 3 | Search RESP18 | Search RESP18 |
3 | DYNAMICAL NETWORK BIOMARKER | 3 | 100% | 3% | 3 | Search DYNAMICAL+NETWORK+BIOMARKER | Search DYNAMICAL+NETWORK+BIOMARKER |
4 | NETWORK BIOMARKER | 2 | 44% | 5% | 4 | Search NETWORK+BIOMARKER | Search NETWORK+BIOMARKER |
5 | PROTEOME REGULATION NETWORK | 1 | 100% | 2% | 2 | Search PROTEOME+REGULATION+NETWORK | Search PROTEOME+REGULATION+NETWORK |
6 | EXPRESSION VARIANCE | 1 | 50% | 1% | 1 | Search EXPRESSION+VARIANCE | Search EXPRESSION+VARIANCE |
7 | LEADING NETWORK | 1 | 50% | 1% | 1 | Search LEADING+NETWORK | Search LEADING+NETWORK |
8 | MULTI BIOMARKER | 1 | 50% | 1% | 1 | Search MULTI+BIOMARKER | Search MULTI+BIOMARKER |
9 | NETWORK MARKERS | 1 | 50% | 1% | 1 | Search NETWORK+MARKERS | Search NETWORK+MARKERS |
10 | RNA INTERFERENCE TECHNOLOGY | 1 | 50% | 1% | 1 | Search RNA+INTERFERENCE+TECHNOLOGY | Search RNA+INTERFERENCE+TECHNOLOGY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONTOLOGY ANALYSIS | 1 | 100% | 2% | 2 |
2 | LEADING BIOMOLECULAR NETWORKS | 1 | 50% | 1% | 1 |
3 | GRAPH ENTROPY | 0 | 25% | 1% | 1 |
4 | TYROSINE PHOSPHATASE FAMILY | 0 | 25% | 1% | 1 |
5 | P55CDC | 0 | 20% | 1% | 1 |
6 | P53 MESSENGER RNA | 0 | 14% | 1% | 1 |
7 | NETWORK BASED APPROACH | 0 | 11% | 1% | 1 |
8 | ENDOCRINE SPECIFIC PROTEIN 18 | 0 | 100% | 1% | 1 |
9 | GHRELIN IMMUNOREACTIVITY | 0 | 100% | 1% | 1 |
10 | GLUD1 GENE | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Edge biomarkers for classification and prediction of phenotypes | 2014 | 2 | 54 | 24% |
Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers | 2014 | 12 | 104 | 6% |
Network biomarkers reveal dysfunctional gene regulations during disease progression | 2013 | 4 | 73 | 14% |
Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling | 2014 | 2 | 64 | 11% |
Detecting disease genes of non-small lung cancer based on consistently differential interactions | 2015 | 0 | 66 | 14% |
Dysplasia and cancer screening in 21st century | 2014 | 1 | 47 | 2% |
Role of traditional chinese medicine and its chemical components in anti-tumor metastasis | 2014 | 0 | 86 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SIBS NOVO NORDISK TRANSLAT PREDIABET | 6 | 28% | 20% | 17 |
2 | ABORAT INNOVAT MATH MODELLING | 4 | 27% | 15% | 13 |
3 | TCM COMPLEX SYST | 2 | 44% | 4.6% | 4 |
4 | SYST BIOLINNOVAT CELL SIGNALING NETW | 2 | 50% | 3.4% | 3 |
5 | SHANGHAI LONGHUA HOSP | 1 | 40% | 2.3% | 2 |
6 | BUDDHIST DALIN TZU CHI HOSP | 1 | 50% | 1.1% | 1 |
7 | THER EUT BRANCH | 1 | 50% | 1.1% | 1 |
8 | AFFILIATED HOSP QUANZHOU 1 | 0 | 33% | 1.1% | 1 |
9 | BIOMOL COMP OURCE | 0 | 25% | 1.1% | 1 |
10 | SIBS NOVO NORDISK TRANSLAT PREDIABETES | 0 | 25% | 1.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000127869 | GENE SET ANALYSIS//ENRICHMENT ANALYSIS//FUNCT GENOM NODE |
2 | 0.0000119572 | PROTEIN INTERACTION NETWORKS//PROTEIN PROTEIN INTERACTION NETWORKS//PROTEIN PROTEIN INTERACTION NETWORK |
3 | 0.0000100055 | NETWORK INFERENCE//GENE REGULATORY NETWORKS//GENE NETWORK INFERENCE |
4 | 0.0000080873 | DIFFERENTIAL GENE EXPRESSION DETECTION//CANCER OUTLIER PROFILE ANALYSIS//BREAST CANC DIAG TREATMENT HENAN |
5 | 0.0000080618 | HERBOXIDIENE//FR901464//PLADIENOLIDE |
6 | 0.0000072593 | SOCIAL COGNIT NETWORKS//JMODELICAORG//LINK DIRECTION |
7 | 0.0000070873 | EARLY WARNING SIGNALS//TIGER BUSH//VEGETATION PATTERNS |
8 | 0.0000070247 | CUERPO NEUROQUIM//NEUROREGENERAT GRP//TEAM ANIM OURCES |
9 | 0.0000053555 | CHD1L//CODON 249//SUPPRESSION OF TUMORIGENICITY |
10 | 0.0000046905 | PHOSGENE//PHARMACOL VASC DIS CARDIOL HEMATOL//PULM INJURY REPAIR |